Trial Outcomes & Findings for Patient-Centered Support for Contraceptive Decision-Making (NCT NCT02078713)

NCT ID: NCT02078713

Last Updated: 2018-11-19

Results Overview

Whether or not a participant is still using the contraceptive method she selected at baseline.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

786 participants

Primary outcome timeframe

4 and 7 months post-enrollment

Results posted on

2018-11-19

Participant Flow

Female patients were approached to participate in the study before appointments at four San Francisco Bay Area clinics between December 2014 and March 2016. Patients are grouped in cluster by provider. Providers of family planning care at the four clinics were approached to participate in the study in October to December 2014.

A total of 2,458 patients were approached to participate in the study. Of these, 1,700 were excluded before assignment (1,642 due to ineligibility, 58 refusals), and 758 enrolled. A total of 36 providers were approached to participate. Eight were excluded before assignment (7 due to ineligibility, 1 refusal), and 28 enrolled.

Participant milestones

Participant milestones
Measure
Contraceptive Decision Support Tool Patients
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control) Patients
Patients in this arm will receive usual family planning care.
Contraceptive Decision Support Tool Providers
Family planning providers randomized to use the Contraceptive Decision Support tool with their patients in the study.
Usual Care (Control) Providers
Family planning providers randomized to deliver usual care to their patient in the study.
Overall Study
STARTED
407
351
15
13
Overall Study
COMPLETED
355
290
15
13
Overall Study
NOT COMPLETED
52
61
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Contraceptive Decision Support Tool Patients
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control) Patients
Patients in this arm will receive usual family planning care.
Contraceptive Decision Support Tool Providers
Family planning providers randomized to use the Contraceptive Decision Support tool with their patients in the study.
Usual Care (Control) Providers
Family planning providers randomized to deliver usual care to their patient in the study.
Overall Study
Lost to Follow-up
49
55
0
0
Overall Study
Pregnant at baseline
3
5
0
0
Overall Study
Enrolled twice
0
1
0
0

Baseline Characteristics

Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Contraceptive Decision Support Tool Patients
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control) Patients
n=345 Participants
Patients in this arm will receive usual family planning care.
Contraception Decision Support Tool Providers
n=15 Participants
Family planning providers randomized to use the Contraceptive Decision Support tool with their patients. Providers were the unit of randomization in this cluster trial
Usual Care (Control) Providers
n=13 Participants
Family planning providers randomized to practice usual care with their patients. Providers were the unit of randomization in this cluster trial
Total
n=777 Participants
Total of all reporting groups
Age, Customized
Age category · 15-19
52 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
43 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
95 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Age, Customized
Age category · 20-24
126 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
121 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
2 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
1 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
250 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Age, Customized
Age category · 25-29
110 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
91 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
2 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
3 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
206 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Age, Customized
Age category · 30-34
68 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
53 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
1 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
3 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
125 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Age, Customized
Age category · 35-39
33 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
22 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
2 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
1 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
58 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Age, Customized
Age category · 40-45
13 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
10 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
4 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
1 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
28 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Age, Customized
Age category · Over 45
0 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
4 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
4 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
8 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Age, Customized
Age category · Missing
2 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
5 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
7 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Sex: Female, Male
Female
404 Participants
n=404 Participants
345 Participants
n=345 Participants
15 Participants
n=15 Participants
12 Participants
n=13 Participants
776 Participants
n=777 Participants
Sex: Female, Male
Male
0 Participants
n=404 Participants
0 Participants
n=345 Participants
0 Participants
n=15 Participants
1 Participants
n=13 Participants
1 Participants
n=777 Participants
Race/Ethnicity, Customized
Race/ethnicity · African American/Black
46 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
34 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
80 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Race/Ethnicity, Customized
Race/ethnicity · Asian or Pacific Islander
59 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
62 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
2 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
123 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Race/Ethnicity, Customized
Race/ethnicity · Hispanic/Latina
160 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
128 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
4 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
4 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
296 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Race/Ethnicity, Customized
Race/ethnicity · White
86 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
85 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
8 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
9 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
188 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Race/Ethnicity, Customized
Race/ethnicity · Other
51 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
32 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
1 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
84 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Race/Ethnicity, Customized
Race/ethnicity · Missing
2 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
4 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
6 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Language spoken during study participation
English
329 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
283 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
15 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
13 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
640 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Language spoken during study participation
Spanish
75 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
62 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
137 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Parental education
8th grade or less
69 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
50 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
119 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
Parental education
Some high school, but did not graduate
38 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
29 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
67 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
Parental education
High school graduate or GED
81 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
69 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
150 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
Parental education
Some college or 2-year degree
83 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
58 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
141 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
Parental education
4-year college graduate or more
129 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
133 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
262 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
Parental education
Missing
4 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
6 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
10 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
% Federal Poverty Line
<100%
183 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
141 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
324 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
% Federal Poverty Line
101-200%
81 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
79 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
160 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
% Federal Poverty Line
>200%
76 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
65 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
141 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
% Federal Poverty Line
Missing
64 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
60 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
124 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
Parity
Nulliparous
265 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
236 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
501 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
Parity
Parous
133 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
104 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
237 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
Parity
Missing
6 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
5 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
11 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.

PRIMARY outcome

Timeframe: 4 and 7 months post-enrollment

Population: Analysis was modified intention to treat. In accordance with the statistical analysis plan, patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1, in which case information from their second enrollment was excluded). Outcome observed in patients only.

Whether or not a participant is still using the contraceptive method she selected at baseline.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Contraceptive Continuation
7 months post-enrollment · Missing
49 Participants
53 Participants
Contraceptive Continuation
4 months post-enrollment · Continuous user of chosen method
249 Participants
228 Participants
Contraceptive Continuation
4 months post-enrollment · Not a continuous user of chosen method
115 Participants
83 Participants
Contraceptive Continuation
7 months post-enrollment · Continuous user of chosen method
201 Participants
174 Participants
Contraceptive Continuation
7 months post-enrollment · Not a continuous user of chosen method
154 Participants
118 Participants
Contraceptive Continuation
4 months post-enrollment · Missing
40 Participants
34 Participants

SECONDARY outcome

Timeframe: Baseline, post-visit survey

Population: Observed in patients only

Patient-reported score on an 11-item factor analysis-validated measure created by the PI to assess patients' satisfaction with the contraceptive counseling experience. The measure consists of 5-point Likert scale items on which patients evaluate provider performance, with item response options ranging from 1 ("Poor") to 5 ("Excellent"). The score range for the total measure is11-55, with 11 as the worst possible score and 55 as the best possible score for provider performance. Analyzed dichotomously, top score (55) versus all lower scores.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Patient Contraceptive Counseling Satisfaction
Top score of 55
261 Participants
194 Participants
Patient Contraceptive Counseling Satisfaction
Less than top score of 55
133 Participants
143 Participants
Patient Contraceptive Counseling Satisfaction
Missing
10 Participants
8 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit survey)

Population: Observed in patients only

Patient response to a 5-point Likert scale item about satisfaction with information that their provider gave them about side effects of their chosen methods during their baseline visit (1=completely unsatisfied, 5=completely satisfied). Analyzed dichotomously as top score of 5 versus \<5.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Patient Satisfaction With Information Received About Side Effects During Counseling
Top score of 5, completely satisfied
325 Participants
253 Participants
Patient Satisfaction With Information Received About Side Effects During Counseling
Less than 5
64 Participants
81 Participants
Patient Satisfaction With Information Received About Side Effects During Counseling
Missing
15 Participants
11 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit survey)

Population: Observed in patients only

Patient report on 5-point Likert scale of satisfaction with baseline visit (1=completely unsatisfied, 5=completely satisfied). Analyzed dichotomously as top score of 5 versus \<5.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Overall Satisfaction With Visit
Completely satisfied
338 Participants
282 Participants
Overall Satisfaction With Visit
Missing
10 Participants
9 Participants
Overall Satisfaction With Visit
Less than completely satisfied
56 Participants
54 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit) and up to 24 months

Population: Observed in patients only

Patient report on 3-point scale of their feelings about provider involvement in contraceptive decision-making: I wish provider had been less involved, provider was involved the right amount, I wiss provider had been more involved.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Shared Decision Making - Feelings About Provider Involvement
Right amount
370 Participants
305 Participants
Shared Decision Making - Feelings About Provider Involvement
Wish provider had been less involved
8 Participants
10 Participants
Shared Decision Making - Feelings About Provider Involvement
Wish provider had been more involved
16 Participants
21 Participants
Shared Decision Making - Feelings About Provider Involvement
Missing
10 Participants
9 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit survey)

Population: Observed in patients only

Patient report of attitude on 3-point scale on how provider expressed preference for contraceptive method choice: Right amount, wish less strongly, wish more strongly.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Shared Decision Making - Provider Appropriately Expressed Preference
No, I wish less
16 Participants
13 Participants
Shared Decision Making - Provider Appropriately Expressed Preference
Yes, exactly right
357 Participants
297 Participants
Shared Decision Making - Provider Appropriately Expressed Preference
No, I wish more
21 Participants
26 Participants
Shared Decision Making - Provider Appropriately Expressed Preference
Missing
10 Participants
9 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit survey)

Population: Observed in patients only

Patient report of satisfaction on a 5-point Likert scale (from 1=completely unsatisfied to 5=completely satisfied) of how the provider helped contraceptive method choice. Analyzed dichotomously as top score of 5 versus \<5.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Shared Decision Making - Satisfaction With How Provider Helped With Choice
Completely satisfied
303 Participants
240 Participants
Shared Decision Making - Satisfaction With How Provider Helped With Choice
Less than completely satisfied
91 Participants
96 Participants
Shared Decision Making - Satisfaction With How Provider Helped With Choice
Missing
10 Participants
9 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit)

Population: Observed in patients only

Patient response to 5-point scale of who made decision on contraceptive method. The original 5 points were the provider by themselves, more provider, both equally, more patient, or provider by themselves. In analysis, these options were collapsed to three points: more provider, both equally, or more patient.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Shared Decision Making - Who Made the Decision?
Patient
286 Participants
244 Participants
Shared Decision Making - Who Made the Decision?
Provider
20 Participants
9 Participants
Shared Decision Making - Who Made the Decision?
Both
88 Participants
83 Participants
Shared Decision Making - Who Made the Decision?
Missing
10 Participants
9 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit survey)

Population: Observed in patients only

Patient report of whether or not provider had preference for contraceptive method choice, reported on a 5-point scale: no preference, slight preference, moderate preference, strong preference, extremely strong preference. Analyzed dichotomously as any preference versus no preference.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Shared Decision Making - Provider Preference
Provider had preference
194 Participants
143 Participants
Shared Decision Making - Provider Preference
Provider had no preference
200 Participants
193 Participants
Shared Decision Making - Provider Preference
Missing
10 Participants
9 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit)

Population: Observed in patients only

Patient Decisional Conflict was measured using the Decisional Conflict Scale (DCS), a validated measure to assess patients' decisional conflict in medical decision making. The DCS includes 16 items about experience of conflict, with 5-point Likert response options ranging from 0 ("Strongly disagree") to 4 ("Strongly agree"). Higher scores indicate less conflict. Top score on DCS (Range: 0-100, analyzed dichotomously as 100 versus \<100). Top scores on subscales also analyzed (Informed decision, Uncertainty, Effective decision, Values clarity, Support, all ranging 0-100 and analyzed dichotomously as 100 versus \<100).

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Patient Decisional Conflict in Contraceptive Choice
Overall score · Top score
100 Participants
76 Participants
Patient Decisional Conflict in Contraceptive Choice
Overall score · Less than top score
294 Participants
260 Participants
Patient Decisional Conflict in Contraceptive Choice
Overall score · Missing
10 Participants
9 Participants
Patient Decisional Conflict in Contraceptive Choice
Informed decision subscale · Top score
199 Participants
145 Participants
Patient Decisional Conflict in Contraceptive Choice
Informed decision subscale · Less than top score
195 Participants
191 Participants
Patient Decisional Conflict in Contraceptive Choice
Informed decision subscale · Missing
10 Participants
9 Participants
Patient Decisional Conflict in Contraceptive Choice
Uncertainty subscale · Top score
164 Participants
112 Participants
Patient Decisional Conflict in Contraceptive Choice
Uncertainty subscale · Less than top score
230 Participants
224 Participants
Patient Decisional Conflict in Contraceptive Choice
Values clarity subscale · Less than top score
198 Participants
182 Participants
Patient Decisional Conflict in Contraceptive Choice
Support subscale · Top score
207 Participants
172 Participants
Patient Decisional Conflict in Contraceptive Choice
Support subscale · Less than top score
187 Participants
164 Participants
Patient Decisional Conflict in Contraceptive Choice
Support subscale · Missing
10 Participants
9 Participants
Patient Decisional Conflict in Contraceptive Choice
Uncertainty subscale · Missing
10 Participants
9 Participants
Patient Decisional Conflict in Contraceptive Choice
Effective decision subscale · Top score
166 Participants
132 Participants
Patient Decisional Conflict in Contraceptive Choice
Effective decision subscale · Less than top score
228 Participants
204 Participants
Patient Decisional Conflict in Contraceptive Choice
Effective decision subscale · Missing
10 Participants
9 Participants
Patient Decisional Conflict in Contraceptive Choice
Values clarity subscale · Top score
196 Participants
154 Participants
Patient Decisional Conflict in Contraceptive Choice
Values clarity subscale · Missing
10 Participants
9 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit)

Population: Observed in patients only

Patient responses to items derived from National Survey of Reproductive Contraceptive Knowledge and previous studies of contraceptive knowledge and attitudes. All items analyzed as correct vs. incorrect.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Patient Knowledge of Contraceptive Options and Features
IUDs are more effective than pills · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Depo is more effective than condoms · Correct
238 Participants
156 Participants
Patient Knowledge of Contraceptive Options and Features
Pills are more effective than condoms · Correct
220 Participants
170 Participants
Patient Knowledge of Contraceptive Options and Features
Pills are more effective than condoms · Incorrect
174 Participants
166 Participants
Patient Knowledge of Contraceptive Options and Features
Pills are more effective than condoms · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
IUDs are more effective than pills · Correct
279 Participants
162 Participants
Patient Knowledge of Contraceptive Options and Features
Methods causing periods to stop are safe · Correct
305 Participants
220 Participants
Patient Knowledge of Contraceptive Options and Features
Methods causing periods to stop are safe · Incorrect
89 Participants
116 Participants
Patient Knowledge of Contraceptive Options and Features
Depo is more effective than condoms · Incorrect
156 Participants
180 Participants
Patient Knowledge of Contraceptive Options and Features
Methods causing periods to stop are safe · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Depo does affect fertility · Incorrect
295 Participants
250 Participants
Patient Knowledge of Contraceptive Options and Features
Depo does affect fertility · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Hormonal IUD does not affect fertility · Correct
238 Participants
165 Participants
Patient Knowledge of Contraceptive Options and Features
Composite IUD knowledge · Correct
146 Participants
66 Participants
Patient Knowledge of Contraceptive Options and Features
Depo is more effective than condoms · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
IUDs are an option for nulliparous young women · Correct
315 Participants
228 Participants
Patient Knowledge of Contraceptive Options and Features
IUDs are an option for nulliparous young women · Incorrect
79 Participants
108 Participants
Patient Knowledge of Contraceptive Options and Features
IUDs are an option for nulliparous young women · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
IUDs are more effective than pills · Incorrect
115 Participants
174 Participants
Patient Knowledge of Contraceptive Options and Features
LARC can be removed early · Correct
261 Participants
211 Participants
Patient Knowledge of Contraceptive Options and Features
LARC can be removed early · Incorrect
133 Participants
125 Participants
Patient Knowledge of Contraceptive Options and Features
LARC can be removed early · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Copper IUDs can act as EC · Correct
89 Participants
33 Participants
Patient Knowledge of Contraceptive Options and Features
Copper IUDs can act as EC · Incorrect
315 Participants
311 Participants
Patient Knowledge of Contraceptive Options and Features
Copper IUDs can act as EC · Missing
0 Participants
1 Participants
Patient Knowledge of Contraceptive Options and Features
After sex, something to prevent pregnancy · Correct
371 Participants
320 Participants
Patient Knowledge of Contraceptive Options and Features
After sex, something to prevent pregnancy · Incorrect
23 Participants
16 Participants
Patient Knowledge of Contraceptive Options and Features
After sex, something to prevent pregnancy · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
EC can prevent pregnancy after sex · Correct
361 Participants
315 Participants
Patient Knowledge of Contraceptive Options and Features
EC can prevent pregnancy after sex · Incorrect
43 Participants
29 Participants
Patient Knowledge of Contraceptive Options and Features
EC can prevent pregnancy after sex · Missing
0 Participants
1 Participants
Patient Knowledge of Contraceptive Options and Features
Pill does not affect fertility · Correct
280 Participants
219 Participants
Patient Knowledge of Contraceptive Options and Features
Pill does not affect fertility · Incorrect
114 Participants
117 Participants
Patient Knowledge of Contraceptive Options and Features
Pill does not affect fertility · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Patch does not affect fertility · Correct
277 Participants
201 Participants
Patient Knowledge of Contraceptive Options and Features
Patch does not affect fertility · Incorrect
117 Participants
135 Participants
Patient Knowledge of Contraceptive Options and Features
Patch does not affect fertility · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Ring does not affect fertility · Correct
270 Participants
192 Participants
Patient Knowledge of Contraceptive Options and Features
Ring does not affect fertility · Incorrect
124 Participants
144 Participants
Patient Knowledge of Contraceptive Options and Features
Ring does not affect fertility · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Depo does affect fertility · Correct
99 Participants
86 Participants
Patient Knowledge of Contraceptive Options and Features
Hormonal IUD does not affect fertility · Incorrect
156 Participants
171 Participants
Patient Knowledge of Contraceptive Options and Features
Hormonal IUD does not affect fertility · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Non-hormonal IUD does not affect fertility · Correct
247 Participants
176 Participants
Patient Knowledge of Contraceptive Options and Features
Non-hormonal IUD does not affect fertility · Incorrect
147 Participants
160 Participants
Patient Knowledge of Contraceptive Options and Features
Non-hormonal IUD does not affect fertility · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Implant does not affect fertility · Correct
233 Participants
164 Participants
Patient Knowledge of Contraceptive Options and Features
Implant does not affect fertility · Incorrect
161 Participants
172 Participants
Patient Knowledge of Contraceptive Options and Features
Implant does not affect fertility · Missing
10 Participants
9 Participants
Patient Knowledge of Contraceptive Options and Features
Composite IUD knowledge · Incorrect
258 Participants
279 Participants
Patient Knowledge of Contraceptive Options and Features
Composite IUD knowledge · Missing
0 Participants
0 Participants

SECONDARY outcome

Timeframe: Reported and analyzed at baseline (post-visit), 4 months and 7 months follow-up

5-point Likert scale item regarding patient satisfaction with contraceptive method chosen at baseline visit. The item is a statement of method satisfaction, and response options range from 1 ("Completely disagree") to 5 ("Completely agree"). A higher score indicates higher satisfaction. Analyzed dichotomously as top score (5) versus all lower scores.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Patient Chosen Contraceptive Method Satisfaction
4 months post-enrollment · Top score of 5
176 Participants
157 Participants
Patient Chosen Contraceptive Method Satisfaction
4 months post-enrollment · Less than top score
183 Participants
148 Participants
Patient Chosen Contraceptive Method Satisfaction
4 months post-enrollment · Missing
45 Participants
40 Participants
Patient Chosen Contraceptive Method Satisfaction
7 months post-enrollment · Missing
47 Participants
55 Participants
Patient Chosen Contraceptive Method Satisfaction
Baseline · Top score of 5
249 Participants
199 Participants
Patient Chosen Contraceptive Method Satisfaction
Baseline · Less than top score
145 Participants
137 Participants
Patient Chosen Contraceptive Method Satisfaction
Baseline · Missing
10 Participants
9 Participants
Patient Chosen Contraceptive Method Satisfaction
7 months post-enrollment · Top score of 5
180 Participants
160 Participants
Patient Chosen Contraceptive Method Satisfaction
7 months post-enrollment · Less than top score
177 Participants
130 Participants

SECONDARY outcome

Timeframe: 7 months follow-up

Population: Observed in patients only

5-point Likert scale question regarding patient satisfaction with the contraceptive method they are currently using. The item is a statement of method satisfaction, and response options range from 1 ("Completely disagree") to 5 ("Completely agree"). A higher score indicates higher satisfaction. Analyzed dichotomously as top score of 5 versus \<5.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Patient Current Contraceptive Method Satisfaction
Missing
48 Participants
55 Participants
Patient Current Contraceptive Method Satisfaction
Completely satisfied
209 Participants
177 Participants
Patient Current Contraceptive Method Satisfaction
Less than completely satisfied
147 Participants
113 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit survey)

Population: Observed in patients only.

Patient ratings of contraceptive methods on the 11-point Global Contraceptive Attitude scale, developed by the PI. To assess overall (or "global") attitude towards use of various methods, patients are asked to respond the following with regard to each method listed in the data table: "Overall, how would you rate each of the following as a birth control method for yourself, (even if you've never used it)?" Response options range from 0 ("Terrible method") to 10 ("Great method"). A higher score on an individual item indicates a more positive attitude towards a method. Analyzed as discrete items with responses of 0 to 10; item scores not combined into an overall scale score.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Patient Attitude Towards Use of Contraceptive Options
Pill
6.26 Units on a scale
Standard Error 0.24
6.55 Units on a scale
Standard Error .289
Patient Attitude Towards Use of Contraceptive Options
Withdrawal
2.8 Units on a scale
Standard Error 0.15
2.98 Units on a scale
Standard Error 0.21
Patient Attitude Towards Use of Contraceptive Options
Patch
5.22 Units on a scale
Standard Error 0.20
5.4 Units on a scale
Standard Error 0.19
Patient Attitude Towards Use of Contraceptive Options
Ring
5.07 Units on a scale
Standard Error 0.18
5.49 Units on a scale
Standard Error 0.26
Patient Attitude Towards Use of Contraceptive Options
Shot
5.05 Units on a scale
Standard Error 0.18
5.35 Units on a scale
Standard Error 0.19
Patient Attitude Towards Use of Contraceptive Options
Hormonal IUD
6.61 Units on a scale
Standard Error .23
6.24 Units on a scale
Standard Error .18
Patient Attitude Towards Use of Contraceptive Options
Non-hormonal IUD
6.3 Units on a scale
Standard Error 0.21
6.29 Units on a scale
Standard Error 0.17
Patient Attitude Towards Use of Contraceptive Options
Implant
5.79 Units on a scale
Standard Error 0.16
6.06 Units on a scale
Standard Error 0.20
Patient Attitude Towards Use of Contraceptive Options
Condoms
6.33 Units on a scale
Standard Error 0.16
6.87 Units on a scale
Standard Error 0.15
Patient Attitude Towards Use of Contraceptive Options
Female sterilization
4.44 Units on a scale
Standard Error 0.27
5.59 Units on a scale
Standard Error 0.24
Patient Attitude Towards Use of Contraceptive Options
Male sterilization
4.98 Units on a scale
Standard Error 0.25
6.08 Units on a scale
Standard Error 0.28

SECONDARY outcome

Timeframe: Baseline (pre- and post-survey)

Population: Only calculated for those patients who reported not having heard of method in pre-survey, and then completed post-survey. All other patients missing for this item and excluded from analysis.

Percentage of patients who reported having heard about a method in the post-survey, but not the pre-survey.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Newly Heard About Methods During Visit
Newly heard of implant · Missing
294 Participants
261 Participants
Newly Heard About Methods During Visit
Newly heard of patch · Yes
39 Participants
38 Participants
Newly Heard About Methods During Visit
Newly heard of patch · No
11 Participants
19 Participants
Newly Heard About Methods During Visit
Newly heard of patch · Missing
354 Participants
288 Participants
Newly Heard About Methods During Visit
Newly heard of ring · Yes
61 Participants
41 Participants
Newly Heard About Methods During Visit
Newly heard of ring · No
24 Participants
23 Participants
Newly Heard About Methods During Visit
Newly heard of ring · Missing
319 Participants
281 Participants
Newly Heard About Methods During Visit
Newly heard of male sterilization · Yes
53 Participants
35 Participants
Newly Heard About Methods During Visit
Newly heard of male sterilization · No
30 Participants
24 Participants
Newly Heard About Methods During Visit
Newly heard of male sterilization · Missing
321 Participants
286 Participants
Newly Heard About Methods During Visit
Newly heard of female sterilization · Yes
59 Participants
44 Participants
Newly Heard About Methods During Visit
Newly heard of hormonal IUD · Yes
79 Participants
46 Participants
Newly Heard About Methods During Visit
Newly heard of hormonal IUD · No
21 Participants
18 Participants
Newly Heard About Methods During Visit
Newly heard of hormonal IUD · Missing
304 Participants
281 Participants
Newly Heard About Methods During Visit
Newly heard of non-hormonal IUD · Yes
104 Participants
84 Participants
Newly Heard About Methods During Visit
Newly heard of non-hormonal IUD · No
23 Participants
31 Participants
Newly Heard About Methods During Visit
Newly heard of non-hormonal IUD · Missing
277 Participants
230 Participants
Newly Heard About Methods During Visit
Newly heard of implant · Yes
80 Participants
58 Participants
Newly Heard About Methods During Visit
Newly heard of implant · No
30 Participants
26 Participants
Newly Heard About Methods During Visit
Newly heard of female sterilization · No
27 Participants
26 Participants
Newly Heard About Methods During Visit
Newly heard of female sterilization · Missing
318 Participants
275 Participants

SECONDARY outcome

Timeframe: Baseline (post-visit survey)

Population: Observed in patients only. Only calculated among those participants who reported ever having had a family planning visit. All others missing.

Patient report on 5-point Likert scale question asking patient to compare this visit to last family planning visit (1=Today was much worse; 5=today was much better). Analyzed dichotomously as top score of 5 versus \<5.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Patient Rating of Visit as "Much Better" Than Previous Family Planning Visit
Much better
142 Participants
104 Participants
Patient Rating of Visit as "Much Better" Than Previous Family Planning Visit
Not much better
144 Participants
140 Participants
Patient Rating of Visit as "Much Better" Than Previous Family Planning Visit
Missing
118 Participants
101 Participants

SECONDARY outcome

Timeframe: Baseline visit

Population: Observed in patients only

Total amount of time a patient spends in a clinic for a family planning visit, from check-in to check-out.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Total Clinic Visit Time
98.40 minutes
Standard Deviation 1.75
86.94 minutes
Standard Deviation 1.71

SECONDARY outcome

Timeframe: Baseline visit

Population: Observed in patients

Total amount of time spent with the provider that is providing contraceptive counseling.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Time Spent With Contraceptive Counseling Provider
44.0 minutes
Standard Deviation 1.21
44.4 minutes
Standard Deviation 1.29

SECONDARY outcome

Timeframe: Change between baseline and end of study (up to 24 months post-enrollment). In multivariate analysis, follow-up score analyzed controlling for site and score at baseline (Analyses 1-3).

Population: Observed in providers only

Provider participants were asked to respond to the Maslach Burnout Inventory on workplace burnout among human services workers. The scale includes 22 items with response options on a Likert scale of 0-6. Individual scores were calculated at both baseline and follow-up for three subscales: emotional exhaustion (Range: 0-54, with higher score representing higher emotional exhaustion), depersonalization (Range: 0-30, with a higher score representing higher depersonalization), and personal accomplishment (Range: 0-48, with a higher score representing more personal accomplishment in the workplace).

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=15 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=13 Participants
Patients in this arm will receive usual family planning care.
Maslach Burnout Inventory
Change in emotional exhaustion
-2.27 Units on a scale
Standard Deviation 9.22
1.07 Units on a scale
Standard Deviation 9.38
Maslach Burnout Inventory
Change in depersonalization
-0.87 Units on a scale
Standard Deviation 4.10
0.46 Units on a scale
Standard Deviation 4.24
Maslach Burnout Inventory
Change in personal accomplishment
-0.80 Units on a scale
Standard Deviation 3.99
2.38 Units on a scale
Standard Deviation 5.30

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline (post-visit survey)

Population: Observed in patients only

Patient report of whether or not patient chose highly effective method at baseline. Highly effective methods include implants, IUDs, and male and female sterilization.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Choice of a Highly Effective Method of Contraception at Baseline
Did not choose highly effective method
249 Participants
221 Participants
Choice of a Highly Effective Method of Contraception at Baseline
Missing
2 Participants
4 Participants
Choice of a Highly Effective Method of Contraception at Baseline
Chose highly effective method
153 Participants
120 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 4 and 7 months post-enrollment

Population: Observed in patients only

Whether patient is using a highly effective contraceptive method at 4 and 7 month follow-up survey. Highly effective methods include implant, IUDs, and male and female sterilization.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 4 months · Yes
264 Participants
230 Participants
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 4 months · No
94 Participants
76 Participants
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 4 months · Missing
46 Participants
39 Participants
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 7 months · Yes
258 Participants
201 Participants
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 7 months · No
99 Participants
90 Participants
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 7 months · Missing
47 Participants
54 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 4 and 7 months post-enrollment

Patient report of whether or not patient is using a highly or moderately effective contraceptive method at 4 and 7 month follow-up survey. As defined by the Centers for Disease Control, moderately effective methods include injectables, pills, patch, vaginal ring, and diaphragm; typical failure rates range from 6-12%. Highly effective methods include implants, IUDs, and male and female sterilization; failure rates are less than 1%.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 4 months post-enrollment · Missing
46 Participants
39 Participants
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 7 months post-enrollment · Yes
258 Participants
201 Participants
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 7 months post-enrollment · No
99 Participants
90 Participants
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 7 months post-enrollment · Missing
47 Participants
54 Participants
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 4 months post-enrollment · Yes
264 Participants
230 Participants
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 4 months post-enrollment · No
94 Participants
76 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 4 months and 7 months from enrollment

Population: Observed in patients only

Incidence of unplanned pregnancy among study participants, as determined by responses of patients who experienced a pregnancy to the 6-item London Measure of Unplanned Pregnancy. The London Measure includes items on attitude towards an experienced pregnancy and behaviors before pregnancy to determine the intendedness of pregnancy. The score range of the London Measure is 0-12, with a score of \<10 indicating unplanned pregnancy and a score of 10 or higher indicating planned pregnancy. We report the percentage of patients who report a pregnancy and report a score of \<10 on the London Measure.

Outcome measures

Outcome measures
Measure
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit. Contraceptive Decision Support Tool: The decision support tool: * Provides an educational session about different aspects of contraception * Elicits patient preferences about different aspects of contraception * Identifies potential contraindications to certain contraceptive methods * Allows the patient to view details about and compare available contraceptive methods * Suggests methods most appropriate based on the patient's preferences * Collects questions the patient may have for her provider * Generates a printout the patient can bring to her contraceptive counseling visit
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
Unplanned Pregnancy
At 4 months post-enrollment · Yes
11 Participants
8 Participants
Unplanned Pregnancy
At 4 months post-enrollment · No
350 Participants
300 Participants
Unplanned Pregnancy
At 4 months post-enrollment · Missing
43 Participants
37 Participants
Unplanned Pregnancy
At 7 months post-enrollment · Yes
24 Participants
11 Participants
Unplanned Pregnancy
At 7 months post-enrollment · No
336 Participants
280 Participants
Unplanned Pregnancy
At 7 months post-enrollment · Missing
44 Participants
54 Participants

Adverse Events

Contraceptive Decision Support Tool Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care (Control) Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Contraceptive Decision Support Tool Providers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care (Control) Providers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Christine Dehlendorf, Principal Investigator

University of California, San Francisco

Phone: 415-206-8712

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place